Error: Could not add to watchlist. X

Pernix Therapeutics Holdings Inc

+ Watchlist
GTAP:GR
Frankfurt
5.50
EUR
0.03
0.61%
As of 02:02:31 ET on 06/03/2015.
Open
5.50
Day Range
5.50 - 5.50
Volume
0
Previous Close
5.53
52Wk Range
4.75 - 11.26
1 Yr Return
9.63%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
239.471
Shares Outstanding (m)
43.540
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.
ADDRESS
10 Park Place Suite 201
Morristown, NJ 07960
United States
PHONE
800-793-2145
  • Douglas Drysdale "Doug"
    Chairman/President/CEO
  • Sanjay S Patel
    CFO/Investor Relations
  • Terence S Novak "Terry"
    Chief Operating Officer
  • Rick Shalaby
    Senior VP:Sales
  • Michael Golembiewski
    VP/Controller
Show More